Decoding the role of CBLB for innate immune responses regulating systemic dissemination during Non-Tuberculous Mycobacteria infection

• Published in: bioRxiv
• Main Authors: Mudalagiriyappa, Srinivasu, Sharma, Jaishree, Abdelaal, Hazem F M, Kelly, Thomas C, Choi, Woosuk, Vieson, Miranda D, Talaat, Adel M, Nanjappa, Som G
• Format: Paper
• Language: English
• Published: Cold Spring Harbor Cold Spring Harbor Laboratory Press 30.05.2020
• Subjects: Dendritic cells; Infections; Inflammation; Innate immunity; Lung diseases; Lymphocytes T; Macrophages; Monocytes; Tuberculosis; Ubiquitin; Ubiquitin-protein ligase
• DOI: 10.1101/2020.05.28.117663

Non-Tuberculous Mycobacteria (NTM) are ubiquitous in nature, present in soil and water, and cause primary leading to disseminated infections in immunocompromised individuals. NTM infections are surging in recent years due to an increase in an immune-suppressed population, medical interventions, and patients with underlying lung diseases. Host regulators of innate immune responses, frontiers for controlling infections and dissemination, are poorly defined during NTM infections. Here, we describe the role of CBLB, an E3-ubiquitin ligase, for innate immune responses and disease progression in a mouse model of NTM infection under compromised T-cell immunity. We found that CBLB thwarted NTM growth and dissemination in a time- and infection route- dependent manner. Mechanistically, we uncovered defects in many innate immune cells in the absence of Cblb, including poor responses of NK cells, inflammatory monocytes, and conventional dendritic cells. Strikingly, Cblb-deficient macrophages were competent to control NTM growth in vitro. Histopathology suggested the lack of early formation of granulomatous inflammation in the absence of CBLB. Collectively, CBLB is essential to mount productive innate immune responses and help prevent the dissemination during an NTM infection under T-cell deficiency. Competing Interest Statement The authors have declared no competing interest.